Bezafibrate treatment: a new medical approach for PBC patients?

Kanda, Tatsuo, Yokosuka, Osamu, Imazeki, Fumio, Saisho, Hiromitsu·2003·Journal of Gastroenterology
DOI 10.1007/s00535-002-1102-7

Cited by (130)

Items 101–130 of 130

  1. Primary Biliary Cholangitis
    Nora V. Bergasa · 2021 · Springer eBooks
  2. Up-to-Date Snapshot of Current and Emerging Medical Therapies in Primary Biliary Cholangitis
    Zakary Ismail Warsop, Nikhil Anand, Husam Al Maliki, Shuell De Souza, Arya Anthony Kamyab, Amin Al Hadad, Laith Alrubaiy · 2024 · Journal of Personalized Medicine
  3. Biochemical and Histological Effectiveness of Long-term Use of Fenofibrate for Asymptomatic Primary Biliary Cholangitis
    Kazufumi Dohmen, Hirofumi Tanaka, Masatora Haruno, Shinichi Aishima · 2016 · Journal of Gastroenterology and Hepatology Research
  4. Efficacy and safety of PPAR agonists in primary biliary cholangitis: a systematic review and meta-analysis
    Wanying Liao, Siyang Fu, Aiming Yang, Yingyun Yang · 2025 · Therapeutic Advances in Gastroenterology
  5. Acute Liver Failure in an Antimitochondrial Antibody-Positive 63-Year-Old Man
    Toru Wakamatsu, Tatsuo Kanda, Akinobu Tawada, Tatsuo Miyamura, Masanori P. Takahashi, Tetsuhiro Chiba, Makoto Arai, Hitoshi Maruyama, Keiichi Fujiwara, Fumio Imazeki et al. · 2012 · Case Reports in Gastroenterology
  6. Oxidative Stress in Autoimmune Liver Disease
    Verónica Martín Domínguez, Eduardo Vilar‐Gómez, Luisa Garcı́a-Buey, Ricardo Moreno‐Otero · 2015 · Oxidative stress in applied basic research and clinical practice
  7. PPAR agonists for primary biliary cholangitis
    Andrea A. Gossard, Gregory James Gores · 2017 · The Lancet. Gastroenterology & hepatology
  8. Cholestasis in hepatitis E virus infection
    Tatsuo Kanda, Reina Sasaki, Takeshi Yokoo, Kazunao Hayashi, Hiroteru Kamimura, Atsunori Tsuchiya, Shuji Terai · 2025 · World Journal of Hepatology
  9. Efficacy and problems in bezafibrate treatment for PBC
    Akira Kaneko, Mitsuhiko Kubo, Shinichiro Watanabe, Koyo HIGASHITANI, Moritoshi YAMAMOTO, N Tatsumi, Akihiro Nakama, Masahide Oshita, Kazuhiro Katayama, Atsuo INOUE et al. · 2005 · Kanzo
  10. Primary Biliary Cholangitis (Formerly Primary Biliary Cirrhosis)
    Palak Jitendrakumar Trivedi, Gideon Morris Hirschfield · 2019 · Wiley eBooks
  11. Primary Biliary Cirrhosis
    E. Jenny Heathcote, Piotr Milkiewicz · 2007 · Wiley eBooks
  12. Efficacy and Safety of PPAR Agonist in Fibrosing Cholangiopathies: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Wanying Liao, Siyang Fu, Aiming Yang, Yingyun Yang · 2024 · SSRN Electronic Journal
  13. Orphan drugs in development for primary biliary cirrhosis: challenges and progress
    Keith D. Lindor, Ahmad Hassan Ali, Thomas Byrne · 2015 · Orphan Drugs Research and Reviews
  14. Beyond PXR and CAR, Regulation of Xenobiotic Metabolism by other Nuclear Receptors
    Martin Wagner, Gernot Zollner, Michael A Trauner · 2008
  15. Bezafibrate Treatment of Primary Biliary Cirrhosis
    Shinji Iwasaki · 2014 · Springer eBooks
  16. Autoimmune Hemolytic Anemia Associated with Primary Biliary Cirrhosis
    Fumio Omata, Shinkichi Sato, Yasuharu Tokuda, Osamu Takahashi, Tsuguya Fukui · 2008 · General Medicine
  17. Impact of Aging on Liver Histological Findings of Autoimmune Liver Diseases
    Yuki Haga, Tatsuo Kanda, Katsuhiro Hagiwara, Reina Sasaki, Masato Nakamura, Shin Yasui, Makoto Arai, Xia Jiang, Shuang Wu, Shingo Nakamoto et al. · 2014 · Diseases
  18. Targets and investigative treatments for primary biliary cholangitis
    Ahmad Hassan Ali, Elizabeth J. Carey, Keith D. Lindor · 2016 · Expert Opinion on Orphan Drugs
  19. Challenges and opportunities in the management of portal hypertension
    Imran Patanwala · 2015
  20. THE ESOPHAGEAL VARICES AND THERAPIES IN PRIMARY BILIARY CIRRHOSIS
    Hidetaka Matsui, Eiji Takeshita, Morikazu Onji · 2005 · Acta gastro-enterologica belgica
  21. Advances in treatment options for patients with primary biliary cholangitis
    Albert Rodrigo Parés · 2017 · Expert Opinion on Orphan Drugs
  22. Biochemical responses to bezafibrate improve long-term outcome in asymptomatic patients with primary biliary cirrhosis refractory to UDCA
    Atsushi TanakaJunko HiroharaYasuni Nakanuma · 2015
  23. Biliary cell lineage. Clinic (diagnosis, treatment).
    Shotaro Sakisaka · 2004 · Kanzo
  24. Cholangitis and cholangiodysplasia
    2006 · Springer eBooks
  25. Gastrointestinal drugs
    S. Dar, Harry R. Dalton · 2005 · Side effects of drugs annual
  26. New Kids on the Block: Peroxisome Proliferator-Activated Receptor Agonists in Primary Biliary Cholangitis
    Thomas Berg, Michael Trauner, Palak Jitendrakumar Trivedi · 2025 · EMJ Hepatology
  27. AGA/AASLD Clinical Practice Guideline on Management of Primary Biliary Cholangitis
    Cynthia Levy, Marlyn J. Mayo, Elizabeth J. Carey, Vincent Lingzhi Chen, David N. Assis, Aparna Goel, Mai Sedki, Shahnaz Sultan, Tamar Taddei, Therese Bittermann et al. · 2026 · Gastroenterology
  28. AASLD AGA clinical Practice Guideline on management of primary biliary cholangitis
    Cynthia Levy, Marlyn J. Mayo, Elizabeth J. Carey, Vincent Lingzhi Chen, David N. Assis, Aparna Goel, Mai Sedki, Shahnaz Sultan, Tamar Hamosh Taddei, Therese Bittermann et al. · 2026 · Hepatology
  29. BindingDB Entry 50006693: Discovery of a Novel Selective Dual Peroxisome Proliferator-Activated Receptor α/δ Agonist for the Treatment of Primary Biliary Cirrhosis.
    BindingDB · 2021 · UC San Diego
  30. Diagnosis and UDCA Treatment of Primary Biliary Cirrhosis
    Atsushi Tanaka · 2014 · Springer eBooks